LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
After crashing 50%+, is this a bargain-basement growth stock?
Investing Articles
A $236bn growth opportunity!? Is this FTSE 100 stock about to skyrocket?
Investing Articles
Could this ‘average’ FTSE 100 stock be one to consider in these difficult times?
Investing Articles
Is this FTSE 100 share a screaming buy to consider after recent falls?
Investing Articles
As the US stock market dives, here’s what Warren Buffett’s doing
Investing
This FTSE 100 stock looks good to me and I’d consider buying it now
Investing Articles
After earnings, is the Hikma Pharmaceuticals share price due a bounce?
Investing Articles
The UK stock market is brimming with hidden value. Here are some top picks to consider in July
Investing Articles
I’m considering these 3 undervalued pharma stocks to buy for my portfolio in April
Investing Articles
2 FTSE 100 shares investors should consider buying for a winning portfolio
Investing Articles
£9,000 in excess savings? I’d buy 457 shares of this dividend stock to target a £1,100 extra income